Sexually Transmitted Disease Surveillance 1993
Division of STD/HIV Prevention December 1994 U.S. Department of Health and Human Services Public Health Service Centers for Disease Control and Prevention National Center for Prevention Services Division of STD/HIV Prevention Surveillance and Information Systems Branch Atlanta, Georgia 30333 Copyright Information All material contained in this report is in the public domain and may be used and reprinted without special permission; citation to source, however, is appreciated. Suggested Citation Division of STD/HIV Prevention. Sexually Transmitted Disease Surveillance, 1993. U.S. Department of Health and Human Services, Public Health Service. Atlanta: Centers for Disease Control and Prevention, December 1994. Copies can be obtained from Information Services, National Center for Prevention Services, Centers for Disease Control and Prevention, 1600 Clifton Road, Mailstop E-06, Atlanta, Georgia 30333. Sources and Limitations of Data CDC Surveillance Data The information in this document was based on cases of sexually transmitted diseases (STDs) reported to the Division of STD/HIV Prevention (DSTD/HIVP), Centers for Disease Control and Prevention (CDC), by the STD control programs and health departments in the 50 states, the District of Columbia, selected cities, and U.S. dependencies and possessions, and independent nations in free association with the United States.* Data were received as summary statistics monthly, quarterly, and annually. Monthly reports included summary data for syphilis by county and state. Quarterly reports included summary data for syphilis, gonorrhea, and other STDs by gender and source of report (public, private, or military) for the 50 states, 64 large cities (most with a population of 200,000), and outlying areas of the United States. Annual reports included summary data for syphilis and gonorrhea by age, race, and gender for the 50 states and six large cities. In addition, data on antimicrobial susceptibility in Neisseria gonorrhoeae were collected through the Gonococcal Isolate Surveillance Project (GISP), a sentinel system of 27 STD clinics and 5 laboratories located throughout the U.S. Provisional data on syphilis and gonorrhea reported to CDC weekly by states for inclusion in the Morbidity and Mortality Weekly Report were not included in this document. Areas differ in their ability to resolve differences in total cases derived from monthly, quarterly, and annual reports. Thus, depending on the database used, there may be discrepancies in total cases in the tables and figures. In most instances, these discrepancies are less than 5% of total reported cases and have minimal impact on national total cases and rates. However, for a specific area, the discrepancies may be larger. Reports and corrections sent to CDC through February 28, 1994, have been included. Those received after this date will appear in subsequent issues. The data in the tables and figures in this document supersede those in all earlier publications. Population Denominators and Rate Calculations Incidence rates were calculated on an annual basis per 100,000 population. For the United States, rates were calculated by using Bureau of the Census population estimates for 1981 through 1989 (Bureau of the Census; United States Population Estimates by Age, Sex and Race: 1980-1989 [Series P-25, No. 1045]; Washington: US Government Printing Office, 1990; and United States Population Estimates by Age, Sex and Race: 1989 [Series P-25, No. 1057]; Washington: US Government Printing Office, 1990). Rates for states and counties were calculated by using published intercensal estimates based on Bureau of the Census population estimates for 1980-1989 (Irwin R; 1980-1989 Intercensal Population Estimates by Race, Sex, and Age; Alexandria, [VA]: Demo-Detail, 1992; machine-readable data file). Rates for 1990 were calculated using population data from the 1990 census (Census of Population and Housing, 1990: Summary Tape File 1 (All States) [machine-readable file]; Washington: Bureau of the Census, 1991), which included information on area (county, state), age (5-year age groups), race (white, black, Asian/Pacific Islander, American Indian/Alaskan Native) and ethnicity (Hispanic). Rates for 1991-1992 were updated from previous issues of this report using postcensal population estimates for 1991-1992 based on the Bureau of the Census data (Irwin R; 1991-1992 Postcensal Population Estimates by Race, Sex, and Age; Alexandria, [VA]: Demo-Detail, 1994; machine-readable data file). Rates for 1993 were calculated using the postcensal 1992 population denominators cited previously. Many cities do not have a separate health jurisdiction that collects and reports cases of STD. For these cities, case numbers and incidence rates are equal to those of the county or counties in which the city is located. For the remaining cities, incidence rates were calculated by using population estimates based on the Bureau of the Census (Irwin R, see above) and a marketing survey (Market Statistics, Inc; Sales and Marketing Management; New York: Bill Communications, Inc, August 1989). Population estimates for areas outside the United States were obtained from the Bureau of the Census (Bureau of the Census; population estimates for Puerto Rico and the outlying areas: 1980 to 1988; Current Population Reports [Series P-25, No. 1049]; Washington: US Government Printing Office, 1989). Population estimates for the outlying areas for 1989-1991 were obtained directly from the health departments in these areas. Rates in these areas for 1992-1993 used 1991 population estimates. The percentage of cases for which race/ethnicity and age were unknown or unspecified differed considerably, depending on year and area. In 1983 and 1984, up to 25% of total U.S. cases were in this category. In these years, states were excluded from analysis if race/ethnicity and age were not reported for the majority of cases. Otherwise, if race/ethnicity or age was unknown or unspecified, cases were distributed according to the cases for which these data were available. Rates of congenital syphilis were calculated using live births from the National Center for Health Statistics (NCHS)(Vital Statistics: Natality Tapes, 1989-1991). Rates before 1989 were calculated using published live birth data (NCHS; Vital Statistics Report, United States, 1988[Vol. 1--Natality]). Case Definitions and Reporting Practices Although most areas generally adhere to the case definitions for STD found in Case Definitions for Public Health Surveillance (MMWR 1990;39(RR-13):1-43), there are significant differences between individual areas in case definitions as well as in the policies and systems for collecting surveillance data. Thus, comparisons of case numbers and rates between areas should be interpreted with caution. However, since case definitions and surveillance activities within a given area remain relatively stable, trends should be minimally affected. In many areas, reporting from publicly supported institutions (e.g., STD clinics) was more complete than from other sources (e.g., private practioners). Thus, the trends may not be representative of all segments of the population. Military cases are not reported as a separate category. In 1989, a new surveillance case definition for congenital syphilis was introduced. The new case definition has greater sensitivity than the former definition. In addition, many areas greatly enhanced active case finding for congenital syphilis during this time. For these reasons, the number of reported cases increased dramatically during 1989-1991. As is true of any change, a period of transition during which trends cannot be clearly interpreted has resulted; however, all reporting areas had implemented the new case definition for reporting all cases of congenital after January 1, 1992. Therefore, the reliability of trends is expected to stabilize for data reported after this date. Reporting of Chlamydia Cases Some areas do not yet have laws or policies for uniform reporting of Chlamydia trachomatis cases, and their reported cases and rates are much lower than expected or zero. Population denominators from these areas are excluded when calculating U.S. total rates. Trends in many areas are more representative of increases in reporting of cases rather than actual trends in disease. Despite the problems with underreporting, we feel it is important to publish the data to emphasize the large numbers of cases of chlamydia being detected in the United States. As areas develop chlamydia prevention and control programs, including improved surveillance systems to monitor trends, the data should improve and become more representative of true trends in disease. Chlamydia testing data for the area-specific figures in the Special Focus Profiles section were published with permission from the following: the Region X Chlamydia Project; the San Francisco Department of Public Health; the Ohio Department of Health; and the Wisconsin State Laboratory of Hygiene. Other Data Sources The information on the number of initial visits to private practioners' offices for sexually transmitted diseases was based on analysis of data from the National Disease and Therapeutic Index (machine-readable files for years 1966-1993). For more information on this database, see IMS America, Ltd; National Disease and Therapeutic Index (NDTI): Diagnosis April 1989-March 1990; Plymouth Meeting (PA): IMS America, Ltd, 1990. The information on patients hospitalized for pelvic inflammatory disease or ectopic pregnancy was based on analysis of data from the National Hospital Discharge Survey (machine-readable files for years 1980-1992), an ongoing nationwide sample survey of short-stay hospitals in the United States, conducted by the National Center for Health Statistics. For more information, see Graves EJ; 1988 Summary: National Hospital Discharge Survey; Advance data No. 185; Hyattsville (MD): National Center for Health Statistics, 1990. *Included among the dependencies, possessions, and independent nations are Guam, Puerto Rico, and the Virgin Islands. These are referred to as "outlying areas of the U.S." in the tables.
This page last reviewed: Monday, February 01, 2016
This information is provided as technical reference material. Please contact us at cwus@cdc.gov to request a simple text version of this document.